We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...
SeaStar Medical plans to conduct an interim analysis at the trial’s 90-day primary endpoint with the first 100 subjects. Given the current pace of enrollment, the company anticipates a Data Safety ...
In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.
Treatments that modulate early effects of aPL antibodies on target cells – that is monocytes or endothelial cells – (first hit) would be more beneficial and potentially less harmful than ...
Copyright 2025 The Associated Press. All Rights Reserved. The FBI now says that the pickup truck driver responsible for a deadly rampage in New Orleans acted alone ...